Antibiotic treatment for acute 'uncomplicated' or 'primary' pyelonephritis: a systematic, 'semantic revision'

International Journal of Antimicrobial Agents

Volumn 28, Issue SUPPL. 1, 2006, Pages 49-63

  Piccoli, Giorgina B ^a   Consiglio, V ^a   Colla, L ^a   Mesiano, P ^a   Magnano, A ^a   Burdese, M ^a   Marcuccio, C ^a   Mezza, E ^a   Veglio, V ^b   Piccoli, G ^a  

^a UNIVERSITY OF TURIN   (Italy)

^b AMEDEO DI SAVOIA HOSPITAL   (Italy)

Author keywords

Acute pyelonephritis; Antibiotic therapy; Evidence based medicine; Randomized controlled trials; Renal scars

Indexed keywords

AMOXICILLIN; AMOXICILLIN PLUS CLAVULANIC ACID; AMPICILLIN; ANTIBIOTIC AGENT; CEFACLOR; CEFADROXIL; CEFALEXIN; CEFIXIME; CEFOTAXIME; CEFPODOXIME PROXETIL; CEFTIBUTEN; CEFTRIAXONE; CEFUROXIME; CILASTATIN PLUS IMIPENEM; CIPROFLOXACIN; ERTAPENEM; FLEROXACIN; GATIFLOXACIN; GENTAMICIN; ISEPAMICIN; LEVOFLOXACIN; LOMEFLOXACIN; MECILLINAM; MIRAXID; NETILMICIN; NORFLOXACIN; PIPERACILLIN PLUS TAZOBACTAM; RUFLOXACIN; TOBRAMYCIN; UNINDEXED DRUG;

ACUTE PYELONEPHRITIS; ANTIBIOTIC THERAPY; ARTICLE; BACTERIUM CULTURE; CLINICAL TRIAL; CONTROLLED DRUG RELEASE; DIAGNOSTIC IMAGING; DRUG DOSE REGIMEN; DRUG SAFETY; HUMAN; INFECTION PREVENTION; LONG TERM CARE; OUTPATIENT CARE; PREVALENCE; PRIORITY JOURNAL; SHORT COURSE THERAPY; TREATMENT DURATION; TREATMENT OUTCOME; URINALYSIS; URINARY TRACT INFECTION;

ACUTE DISEASE; ANTI-BACTERIAL AGENTS; HUMANS; PYELONEPHRITIS; RANDOMIZED CONTROLLED TRIALS; TREATMENT OUTCOME;

EID: 33746753270     PISSN: 09248579     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ijantimicag.2006.05.017     Document Type: Article

References (69)

1. Heptinstall R.H. Pyelonephritis: pathologic features. In: Heptinstall R.H. (Ed). Pathology of the kidney. 4th ed. (1992), Little Brown, Boston 1489-1561
2. Risdon R.A. Pyelonephritis and reflux nephropathy. In: Tisher C., and Brenner B. (Eds). Renal pathology (1989), JB Lippincott Company, Philadelphia 775-808
3. Stamm W.E. Urinary tract infections and pyelonephritis. In: Isselbacher K.J., Braunwald E., Wilson J.D., Martin J.B., Fauci A.S., and Kasper D.L. (Eds). Harrison's principles of internal medicine. 13th ed. (1994), McGraw-Hill, New York 548-554
4. Talner L.B., Davidson A.J., Lebowitz R.L., Dalla Palma L., and Goldman S.M. Acute pyelonephritis: can we agree on terminology?. Radiology 192 (1994) 297-305
5. Soulen M.C., Fishman E.K., and Goldman S.M. Sequelae of acute renal infections: CT evaluation. Radiology 173 (1989) 423-426
6. Tsugaya M., Hirao N., Sakagami H., Ohtaguro K., and Washida H. Renal cortical scarring in acute pyelonephritis. Br J Urol 69 (1992) 245-249
7. Lee B.F., Chiou Y.Y., Chuang C.M., Wu P.S., Wu Y.C., and Chiu N.T. Evolution of differential renal function after acute pyelonephritis. Nucl Med Commun 23 (2002) 1005-1008
8. Biggi A., Dardanelli L., Cussino P., et al. Prognostic value of the acute DMSA scan in children with first urinary tract infection. Pediatr Nephrol 16 (2001) 800-804
9. Wallin L., Helin I., and Bajc M. Follow-up of acute pyelonephritis in children by Tc-99 m DMSA scintigraphy: quantitative and qualitative assessment. Clin Nucl Med 26 (2001) 423-432
10. Gentry L.O., Wood B.A., Martin M.D., and Smythe J. Cefamandole alone and combined with gentamicin or tobramycin in the treatment of acute pyelonephritis. Scand J Infect Dis 12 Suppl. 25 (1980) S96-S100
11. Bucht H. Recent trends in the therapy of urinary tract infections. Infection 7 Suppl. 4 (1979) S309-S312
12. Benador D., Benador N., Slosman D.O., Nussle D., Mermillod B., and Girardin E. Cortical scintigraphy in the evaluation of renal parenchymal changes in children with pyelonephritis. J Pediatr 124 (1994) 17-20
13. Sreenarasimhaiah V., and Alon U.S. Uroradiologic evaluation of children with urinary tract infection: are both ultrasonography and renal cortical scintigraphy necessary?. J Pediatr 127 (1995) 373-377
14. Rosenberg A.R., Rossleigh M.A., Brydon M.P., Bass S.J., Leighton D.M., and Farnsworth R.H. Evaluation of acute urinary tract infection in children by dimercaptosuccinic acid scintigraphy: a prospective study. J Urol 148 (1992) 746-749
15. Jakobsson B., Nolstedt L., Svensson L., Soderlundh S., and Berg U. 99mTechnetium-dimercaptosuccinic acid scan in the diagnosis of acute pyelonephritis in children: relation to clinical and radiological findings. Pediatr Nephrol 6 (1992) 328-334
16. Ditchfield M.R., Summerville D., Grimwood K., et al. Time course of transient cortical scintigraphic defects associated with acute pyelonephritis. Pediatr Radiol 32 (2002) 849-852
17. Peters C.A., and Nielsen G.P. Case 17-2000: a 21-week-old girl with fever and a renal mass. N Engl J Med 342 (2000) 1733-1740
18. Kawashima A., and LeRoy A.J. Radiologic evaluation of patients with renal infections. Infect Dis Clin North Am 17 (2003) 433-456
19. Stamm W.E., and Hooton T.M. Management of urinary tract infections in adults. N Engl J Med 329 (1993) 1328-1334
20. Bergeron M.G. Treatment of pyelonephritis in adults. Med Clin North Am 79 (1995) 619-649
21. Naber K.G., Bergman B., Bishop M.C., et al. EAU guidelines for the management of urinary and male genital tract infections. Urinary Tract Infection (UTI) Working Group of the Health Care Office (HCO) of the European Association of Urology (EAU). Eur Urol 40 (2001) 576-588
22. Cooper B. Pyelonephritis in non-pregnant women. Clin Evid 7 (2002) 1758-1763 Update in: Clin Evid 2002;8:1992-8
23. Dickersin K., Scherer R., and Lefebvre C. Identifying relevant studies for systematic reviews. Br Med J 309 (1994) 1286-1291
24. Naber K.G., Bartnicki A., Bischoff W., et al. Gatifloxacin 200 mg or 400 mg once daily is as effective as ciprofloxacin 500 mg twice daily for the treatment of patients with acute pyelonephritis or complicated urinary tract infections. Int J Antimicrob Agents 23 Suppl. 1 (2004) S41-S53
25. Talan D.A., Klimberg I.W., Nicolle L.E., Song J., Kowalsky S.F., and Church D.A. Once daily, extended release ciprofloxacin for complicated urinary tract infections and acute uncomplicated pyelonephritis. J Urol 171 (2004) 734-739
26. Chong C.Y., Tan A.S., Ng W., Tan-Kendrick A., Balakrishnan A., and Chao S.M. Treatment of urinary tract infection with gentamicin once or three times daily. Acta Paediatr 92 (2003) 291-296
27. Montini G., Murer L., Gobber D., et al. Oral vs. initial intravenous antibiotic treatment of urinary tract infections in children: a multicentre study. Nephrol Dial Transplant 18 Suppl. 4 (2003) S816
28. Cox C.E., Marbury T.C., Pittman W.G., et al. A randomized, double-blind, multicenter comparison of gatifloxacin versus ciprofloxacin in the treatment of complicated urinary tract infection and pyelonephritis. Clinical Ther 24 (2002) 223-236
29. Jimenez-Cruz F., Jasovich A., Cajigas J., et al. A prospective, multicenter, randomized, double-blind study comparing ertapenem and ceftriaxone followed by appropriate oral therapy for complicated urinary tract infections in adults. Urology 60 (2002) 16-22
30. Naber K.G., Savov O., and Salmen H.C. Piperacillin 2 g/tazobactam 0.5 g is as effective as imipenem 0.5 g/cilastatin 0.5 g for the treatment of acute uncomplicated pyelonephritis and complicated urinary tract infections. Int J Antimicrob Agents 19 (2002) 95-103
31. Sanchez M., Collvinent B., Miro O., et al. Short-term effectiveness of ceftriaxone single dose in the initial treatment of acute uncomplicated pyelonephritis in women. A randomised controlled trial. Emerg Med J 19 (2002) 19-22
32. Tomera K.M., Burdmann E.A., Reyna O.G., et al. Ertapenem versus ceftriaxone followed by appropriate oral therapy for treatment of complicated urinary tract infections in adults: results of a prospective, randomized, double-blind multicenter study. Antimicrob Agents Chemother 46 (2002) 2895-2900
33. Baker P.C., Nelson D.S., and Schunk J.E. The addition of ceftriaxone to oral therapy does not improve outcome in febrile children with urinary tract infections. Arch Pediatr Adolesc Med 155 (2001) 135-139
34. Benador D., Neuhaus T.J., Papazyan J.P., et al. Randomised controlled trial of three day versus 10 day intravenous antibiotics in acute pyelonephritis: effect on renal scarring. Arch Dis Child 84 (2001) 241-246
35. Carapetis J.R., Jaquiery A.L., Buttery J.P., et al. Randomized, controlled trial comparing once daily and three times daily gentamicin in children with urinary tract infections. Pediatr Infec Dis J 20 (2001) 240-246
36. Cronberg S., Banke S., Bergman B., et al. Fewer bacterial relapses after oral treatment with norfloxacin than with ceftibuten in acute pyelonephritis initially treated with intravenous cefuroxime. Scand J Infect Dis 33 (2001) 339-343
37. Gok F., Duzova A., Baskin E., Ozen S., Besbas N., and Bakkaloglu A. Comparative study of cefixime alone versus intramuscular ceftizoxime followed by cefixime in the treatment of urinary tract infections in children. J Chemother 13 (2001) 277-280
38. Le Conte P., Simon N., Bourrier P., et al. Acute pyelonephritis. Randomized multicenter double-blind study comparing ciprofloxacin with combined ciprofloxacin and tobramycin. Presse Medi 30 (2001) 11-15 [in French]
39. Levtchenko E., Lahy C., Levy J., Ham H., and Piepsz A. Treatment of children with acute pyelonephritis: a prospective randomized study. Pediatr Nephrol 16 (2001) 878-884
40. Naber K.G., Schoenwald S., and Hauke W. Cefpodoximproxetil bei patienten mit akuter unkomplizierter pyeloneephritis. Internationale, prospektive, randomisierte vergleichsstudie versus ciprofloxacin unter praxisbedingungen. Chemother J 10 (2001) 29-34
41. Vilaichone A., Watana D., and Chaiwatanarat T. Oral ceftibuten switch therapy for acute pyelonephritis in children. J Med Assoc Thai 84 Suppl. 1 (2001) S61-S67
42. Kafetzis D.A., Maltezou H.C., Mavrikou M., et al. Isepamicin versus amikacin for the treatment of acute pyelonephritis in children. Int J Antimicrob Agents 14 (2000) 51-55
43. Talan D.A., Stamm W.E., Hooton T.M., et al. Comparison of ciprofloxacin (7 days) and trimethoprim-sulfamethoxazole (14 days) for acute uncomplicated pyelonephritis in women: a randomized trial. J Am Med Assoc 283 (2000) 1583-1590
44. Hoberman A., Wald E.R., Hickey R.W., et al. Oral versus initial intravenous therapy for urinary tract infections in young febrile children. Pediatrics 104 (1999) 79-86
45. Mombelli G., Pezzoli R., Pinoja-Lutz G., Monotti R., Marone C., and Franciolli M. Oral vs. intravenous ciprofloxacin in the initial empirical management of severe pyelonephritis or complicated urinary tract infections: a prospective randomized clinical trial. Arch Intern Med 159 (1999) 53-58
46. Richard G.A., Klimberg I.N., Fowler C.L., Callery-D'Amico S., and Kim S.S. Levofloxacin versus ciprofloxacin versus lomefloxacin in acute pyelonephritis. Urology 52 (1998) 51-55
47. Schaad U.B., Eskola J., Kafetzis D., et al. Cefepine vs. ceftazidime treatment of pyelonephritis: a European, randomized, controlled study of 300 pediatric cases. European Society for Paediatric Infectious Diseases (ESPID) Pyelonephritis Study Group. Pediatr Infect Dis J 17 (1998) 639-644
48. Cole P. Pharmacologic and clinical comparison of cefaclor in immediate-release capsule and extended-release tablet forms. Clin Ther 19 (1997) 617-625
49. François P., Bensman A., Bégué P., et al. Assesment of the efficacy and cost efficiency of two strategies in the treatment of acute pyelonephritis in children: oral cefixime or parenteral ceftriaxone after an initial iv combination therapy. Med Mal Infect 27 Suppl. 6 (1997) 667-673 [in French]
50. Moreno-Martinez A., Mensa J., Martinez J.A., et al. Cefixime versus amoxicillin plus netilmicin in the treatment of community-acquired non-complicated acute pyelonephritis. Med Clin (Barc) 111 (1998) 521-524 [in Spanish]
51. Sandberg T., Alestig K., Eilard T., et al. Aminoglycosides do not improve the efficacy of cephalosporins for treatment of acute pyelonephritis in women. Scand J Infect Dis 29 (1997) 175-179
52. Bakkaloglu A., Saatci U., Soylemezoglu O., et al. Comparison of ceftriaxone versus cefotaxime for childhood upper urinary tract infections. J Chemother 8 (1996) 59-62
53. Bailey R.R., Begg E.J., Smith A.H., et al. Prospective, randomized, controlled study comparing two dosing regimens of gentamicin/oral ciprofloxacin switch therapy for acute pyelonephritis. Clin Nephrol 46 (1996) 183-186
54. Bach D., van den Berg-Segers A., Hubner A., van Breukelen G., Cesana M., and Pletan Y. Rufloxacin once daily versus ciprofloxacin twice daily in the treatment of patients with acute uncomplicated pyelonephritis. J Urol 154 (1995) 19-24
55. François P., Croizé J., Bost C., and Wollschlager K. Comparative study of cefixime versus amoxicillin-clavulanate for oral treatment of urinary tract infections in children. Arch Pédiatr 2 (1995) 136-142 [in French]
56. de Gier R., Karperien A., Bouter K., et al. A sequential study of intravenous and oral Fleroxacin for 7 or 14 days in the treatment of complicated urinary tract infections. Int J Antimicrob Agents 6 (1995) 27-30
57. Cronberg S., Banke S., Bruno A.M., et al. Ampicillin plus mecillinam vs. cefotaxime/cefadroxil treatment of patients with severe pneumonia or pyelonephritis: a double-blind multicentre study evaluated by intention-to-treat analysis. Scand J Infect Dis 27 (1995) 463-468
58. Sturm W. Isepamicin versus amikacin in the treatment of urinary tract infection. J Chemother 7 Suppl. 2 (1995) 149-154
59. Verzasconi R., Rodoni P., Monotti R., Marone C., and Mombelli G. Amoxicillin and clavulanic acid versus amoxicillin plus gentamicin in the empirical initial treatment of urinary tract infections in hospitalized patients. Schweiz Med Wochenschr 125 (1995) 1533-1539 [in German]
60. Meyrier A., Condamin M.C., Fernet M., et al. Frequency of development of early cortical scarring in acute primary pyelonephritis. Kidney Int 35 (1989) 696-703
61. Wegenke J.D., Malek G.H., Alter A.J., and Olson J.G. Acute lobular nephronia. J Urol 135 (1986) 343-345
62. Lee J.K., McClennan B.L., Melson G.L., and Stanley R.J. Acute focal bacterial nephritis: emphasis on gray scale sonography and computed tomography. AJR Am J Roentgenol 35 (1980) 87-92
63. Soulen M.C., Fishman E.K., and Goldman S.M. Sequelae of acute renal infections: CT evaluation. Radiology 173 (1989) 423-426
64. Lee B.F., Chiou Y.Y., Chuang C.M., Wu P.S., Wu Y.C., and Chiu N.T. Evolution of differential renal function after acute pyelonephritis. Nucl Med Commun 23 (2002) 1005-1008
65. Wallin L., Helin I., and Bajc M. Follow-up of acute pyelonephritis in children by Tc-99m DMSA scintigraphy: quantitative and qualitative assessment. Clin Nucl Med 26 (2001) 423-432
66. Jakobsson B., Berg U., and Svensson L. Renal scarring after acute pyelonephritis. Arch Dis Child 70 (1994) 111-115
67. Raz R., Sakran W., Chazan B., Colodner R., and Kunin C. Long-term follow-up of women hospitalized for acute pyelonephritis. Clin Infect Dis 37 (2003) 1014-1020
68. Michael M., Hodson E.M., Craig J.C., Martin S., and Moyer V.A. Short compared with standard duration of antibiotic treatment for urinary infection: a systematic review of randomized controlled trials. Arch Dis Child 87 (2002) 118-123
69. Keren R., and Chan E. Short vs. standard duration antibiotic treatment for UTIs: a comparison of two meta-analyses. Arch Dis Child 88 (2003) 89-91